ABSTRACT
INTRODUCTION
Novel drug delivery system has reached its pinnacle in last few years. Sustained drug delivery system is advantageous with its prolonged drug release mechanism which is desirable from the therapeutic point of view, for the treatment of chronic pain syndromes like nocturnal asthma, angina pectoris and rheumatoid arthritis. 1 Sustained drug delivery systems maintain the drug level at the therapeutic optimum which is needed in the blood in a numbers of pathological conditions. Therefore, the preparation of controlled and sustained drug delivery system is one of the most important tasks of pharmaceutical technologist. 2 Research has been performed on prodrug, pH, time dependent and polysaccharide based drug delivery system leading to unsatisfactory results, so further investigation on natural gum based microsphere was initiated. [3] [4] [5] Multiunit sustained release formulation like microspheres 19-07-2015 pass through the gut as if a solution avoiding the vagaries of gastric emptying and different transient rates and thereby, release drugs more uniformly, and spread over a large area of absorbing mucosa decreasing dose dumping and preventing exposure to high drug concentration. 6, 7 Drug release retarding polymers are the key performers in designing a dosage form for oral sustained release formulation. 8 The natural polysaccharides (excipients of natural origin) are the attractive alternative product because of their reliability, biocompatibility, biodegradability, sustainability, low toxicity and low cost compared to synthetic product. 9 Natural Polysaccharide such as guar gum, xanthan gum, and locast bean gum has been investigated for their use in Novel drug delivery system. 10 They remain undigested in stomach but get degraded by different anaerobic microflora in the intes-tine. 11 Gum Katira was selected as the matrix forming material because of its well-established biocompatibility, non toxic and safe material for the use in food and pharmaceutical industries. 12 Gum Katira is a novel heteropolysaccharide isolated from Cochlospermum religiosum and consists of D-galactose, D-galactouronic acid and L-rhamnose in a molecular ratio 2:1:3 respectively together with traces of a ketohexose. 13 This gum is pale, semi transparent and swells to form a pasty transparent mass with water.
14 Different physiochemical properties of Gum Katira such as solubility, percentage of swelling, and rheogram etc have been studied. Increment in shear stress on increasing shear rate confirmed the pseudoplastic nature that may be a suitable characteristic for the controlled and sustained release drug delivery formulations. 15 The instrumental techniques like SEM, DSC, X ray diffraction, FT-IR, etc were performed to establish that Gum Katira has no interactions with the ingredients used in the microsphere formulation containing a polymeric substance as a carrier and a coating material. Etodolac, a non steroidal anti-inflammatory drug, used in the treatment of various acute and chronic pain syndromes like osteoarthritis, rheumatoid arthritis and other types of joint pain. 16 Etodolac is taken as a model drug because of its short half life, low water solubility and ready absorbility throughout the gastrointestinal tract. 17, 18 However, its immediate release formulations shows severe side effects like gastric irritation, bleeding, ulceration and eventually wall perforation especially in chronic dosing led to the formulation of microsphere, a sustained release dosage form. 19 Eudragit which is one of the most thoroughly investigated synthetic polymers for sustained drug delivery system is being used as a coating material in this formulation. 20 , 21 Eudragit RS 100 and RL 100 are taken due to their biocompatibility, good stability, easy fabrication and insolubility in gastric juice. [22] [23] [24] [25] In contrary to conventional dosage forms like tablets and capsules, formulations which are present in the market with better effectiveness also have higher side effects on gastrointestinal system 26 and cardiovascular system 27 on administration of more than 400mg dose. The use of microsphere for drug delivery is not limited to any specific illness, rather they can be widely applied in many situations where continuous or controlled drug administration is essential.
MATERIALS AND METHODS

Materials
Crude Gum Katira was collected from the Seoni district of Madhya Pradesh. Etodolac was obtained as a gift sample from Fleming Laboratories Limited Medak district, Andhra Pradesh, India. Eudragit RS100 and Eudragit RL100 were purchased from the Yarro Chem Products Mumbai (India), Dichloromethane, Tween 80 and Span 20 (Merck, India), and all other reagents were of analytical grade obtained commercially and used as received.
Methods
Collection and Purification of Gum Katira
Crude gum was collected as dried exudates from the branches of the fibrous exudates of plant Chochlospermum religiosum (Hindi: Galgal) in the month of December from Seoni district of Madhya Pradesh, India. For purification larger dust particles were removed manually and air dried well. Dried gum exudates was then kept overnight in water. Gum was allowed to swell fully to form ribbon shaped transparent mass. Again larger visible foreign particles were removed carefully. The transparent mass was stirred vigorously using mechanical stirrer for 3 hrs. The remaining minute dust particles were then removed manually. The finally obtained white material was then oven dried at 70 0 C for 2 days. Particle size of oven dried material was reduced as much as possible by using mortar and pestle and finally kept in air dried container for optimum storage.
Solubility
The solubility of Gum Katira was evaluated randomly in water, acetone, chloroform, ethanol and most of the other organic solvents. As a result, the gummy exudates were found to be slightly soluble in water and insoluble in most of organic solvents used like Ethanol, chloroform and acetone.
Particle size and Melting Point determination
The particle size of the Gum Katira was determined by the help of Zetasizer (ASU), Model No. Nano ZS 90, Malvern, UK. The melting point of the Gum Katira was determined by digital melting point apparatus (model VMP-D, Veego, Mumbai). For this the gum powder was taken in the capillary tube of the apparatus. As the temperature of the apparatus rises, solid starts transforming into liquid but in case of natural polysaccharides the transition from solid to liquid is followed by charring during the melting process. Gum Katira powder starts charring at 80-90ºC.
Determination of Moisture content
Moisture content of Gum Katira was determined by Carl Fischer titration method. The gum powder was dispersed in methanol, stirred well for 5 minutes to remove the water and titrated with standardized Karl Fischer reagent till the end point. Moisture content was calculated using the following formula. Moisture content (%) = V 1 ×W e /S w × 100 Where V 1 is the volume of Karl Fischer reagent used, W e is the water equivalent and S w is the weight of sample. Water equivalent is 5.2; 15 ml of reagent is equal to 75 mg of water.
Microbial Load Study
Microbial load of the Gum Katira was observed on fresh sample and 10 months older sample. The sample was analyzed for total aerobic microbial count and fungal count by pour plate method. 1 µm/ml of gum dispersion was incubated in soybean casein digest sugar medium, poured inpetridish and allowed to solidify. The plate was left for 1 hr at 10 0 C and incubated at 37 0 C for a day. The total no of colonies formed were counted. Total fungal count was done using potato dextrose agar medium. The plates are incubated at room temperature for 72 hrs.
Swelling characteristic of Gum Katira
Rate of swelling/ hydration of ELGKM and ELSAM in same concentration were evaluated to study the mechanism of drug release from the hydrated gum and extent of water uptake by the gum. Swelling capacity was evaluated in terms of weight gain by the microsphere. Accurately weighed microspheres were placed on petridishes having the dissolution media (pH 1.2 HCl media for 2 hrs and pH 6.8 phosphate buffers for 10 hrs). Swollen Microspheres were withdrawn periodically from the medium and weighed in an electronic balance (Model No. D455001482, Shimadzu corp, Japan) after removing the excess surface water using tissue paper. The same process was repeated for 12 
Rheological Study
The Rheological properties were determined by using Rheometer (Anton Paar, and Model No. MRC 102, Austria). For this Gum Katira (1%w/v, 2%w/v) dispersion and sodium alginate (1%w/v) solution were prepared with distilled water and allowed to stand for 24 hrs. Then the gum solution was analyzed at different shear stress vs shear rate and shear rate vs viscosity at different time intervals at 12 th hr and 24 th hr respectively.
Toxicity Study
The acute toxicity study was carried out in adult Swiss albino mice (20-25 g ) by "fixed dose" method of OECD (Organization for Economic Cooperation and development) guideline no.423 and 407 respectively. The subacute toxicity study was conducted on male wistar rat (150-200 g). The solution of gum katira at dose of 100, 200 and 400 mg/kg body weight was administered orally to three groups of six rats respectively in every 24 hrs for 30 days and a control received vehicle of same volume. The toxic manifestation i.e. body weight, mortility and behavioral changes were regularly monitored. After thirty days all the surviving animals were fastened overnight and anaesthetized with ether and the heparinized blood samples were collected for determination of haematological parameters followed by sacrificing the animals for the collection of internal organs kidney and liver. The collected organs were then preserved in 10% formaldehyde solution for histopathological examination. The research was conducted in accordance with the ethical rules on animal experimentation approved by Ethical committee, Department of Pharmaceutical Technology, Jadavpur University (Approval No: 147/1999/CPCSEA).
Determination of λ max of Drug
A solution of Etodolac having a conc. 1µg/ml was prepared in acid (pH-1.2) and phosphate buffer (pH-6.8) separately. UV spectrum was taken using double beam spectrophotometer (MULTISKAN GO, Thermo Scientific). The solution was scanned in the range of 200-400 nm. The wavelength of maximum absorption of Etodolac was found to be 224 nm in both the cases.
Determination of Melting Point of Drug
The melting point of Etodolac was determined by open capillary method using melting point apparatus VEEGO, (Model No.VMP-DS). The melting point of Etodolac was found to be 150.5-151.5ºC.
Preparation of Microsphere
Etodolac microspheres were prepared by double-emulsion solvent evaporation technique. Matrix material Gum Katira (50 mg) was mixed with distilled water to form a homogeneous mixture in magnetic stirrer for 30 minutes with a constant temperature of 40-45 0 C. Etodolac (50 mg) was added to the homogeneous mixture and stirring was continued for another 30 minutes. This mixture was then dispersed in a solution of Eudragit RS and RL 100, Dichloromethane, Acryflow and span 20 through a 20 guage syringe. The above mixture was homogenized well for 5 minutes using homogenizer to form W1/O emulsion. Another solution of distilled (100 ml) water containing Tween 80 was subjected to mechanical stirring (700-800 rpm) and to it the previously prepared W 1 /O emulsion was added drop wise using a 16 guage syringe to form W1/O/W2 emulsion with a continues stirring for 1-1.5 hrs. The resultant microspheres formed were washed with distilled water followed by air drying for 24 hrs and final storage in desiccators for further use.
Percentage of Yield and Encapsulation efficiency of the Microspheres
The percentage of yield is calculated to know the maximum practical yield of the products. Etodolac loaded microspheres were prepared having production yield near about 80-95%. The percentage yield of prepared formulation was determined by using the formula:
Crushed and Powder 30 mg of Etodolac loaded Microspheres were dissolved in 5 ml of Dichloromethane (DCM). This solution was stirred for 1hr using magnetic stirrer for the complete dissolution of Polymer in DCM. 45 ml of phosphate buffer pH-6.8 was added to this solution. This solution was magnetically stirred for 1 hr at 40-45ºC and then filtered. About 4 ml of filtered solution was taken and added to 21 ml of fresh phosphate buffer to make 25 ml of aliquot. The absorbance of the final solution was measured at 224 nm using double beam UV-Visible spectrophotometer against phosphate buffer pH-6.8 as blank and calculation was done for the percentage of drug loading in sample. Drug loading efficiency was found to range between 45-60%. Efficiency of drug loading for each batch was calculated in terms of percentage of drug loading (PDL) as per the following formula:
PDL = [Practical drug content/Theoretical drug content] X 100
Scanning Electron Microscope Analysis
Scanning Electron Microscope (SEM) studies were carried out by using JEOL MAKE (UK), (MODEL-JSM6360). Microspheres were mounted on conducting stubs using double sided adhesive tape and vacuum coated with gold palladium film using a sputter coater (Edward S-150, UK). Images were taken using 17 kV electron beam intensity in a scanning electron micro-scope to examine the surface morphology of the samples.
FTIR Spectroscopic Study
Fourier Transform Infra Red (FTIR) spectroscopy was performed on IR-Prestige-21, Shimadzu make, Japan. FTIR study was carried on Etodolac, Gum Katira and Microsphere shows their characteristic peaks in the region from 400-4000 cm -1 .
Differential Scanning Calorimetric Analysis
Differential Scanning Calorimetric (DSC) was performed to study the changing thermal behavior of the drug, polymer and gum during formulation. Thermograms are evaluated to detect the melting point and change in enthalpy of melting of the samples. Thermograms of Etodolac, Gum Katira and formulation were prepared by Model No. Pyris Diamond TG/DTA, Perkin Elmer (SINGAPORE), Nitrogen Atmosphere (150 ml/min). Platinum crucible was used with alpha alumina powder as reference to study the changing thermal behavior of the drug, polymer and the gum.
XRD Study
X-ray diffractometry of Gum Katira, Etodolac and Etodolac loaded Microsphere were performed by a X-Ray Diffractometer using Model no. Ultima-III, Regaku make (Japan), Cu target slide 10 mm. to observe the physical state of Etodolac in the Microsphere.
In vitro Drug Release Study
In vitro drug release studies were performed by using USP II dissolution test apparatus (Model TDP-06P, Electro Lab, Mumbai, India). Dissolution studies of all microspheres were carried out in 0.1 N HCl, pH-1.2 acidic media for an initial 2 hrs followed by USP phosphate buffer, pH 6.8 for the rest of the period at 75 rpm maintained at a temperature of 37ºC ± 0.5ºC. Aliquots were withdrawn at specific time interval and replenished immediately with the same volume of fresh solution. The drug release was analyzed by UV-Visible Spectrophotometer (MULTISKAN GO, Thermo Scientific) at 224 nm. All release studies were triplicated. The drug release behavior of ELGKM was compared with ELSAM and blank Microsphere.
Statistical analysis
The data obtained were analyzed statistically using oneway ANOVA and t-test by using Graph Pad prism 5.
RESULTS AND DISCUSSIONS
Physiochemical Evaluation of Gum Katira
Solubility
Gum Katira is slightly soluble in water and form reddish brown color dispersion. It is practically insoluble in ethanol, acetone, chloroform and most of the organic solvent. The gum forms a viscous colloidal dispersion with warm water. This type of matrix forming solu-tion is suitable for the development of prolonged drug release formulation.
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Particle size and Melting point determination
The particle size of gum was in the range of 100-200 µm. The calculated average diameter of the Gum Katira powder is found to be about 123 µm, which is within the desired range of 75-125 µm for most of the gum powder particles used in various sustained release formulation. The natural products have a range of melting point rather than a definite melting point of pure products. During the melting process the transition of solid phase to liquid phase of gums is always accompanied by charring. Similar, charring characteristic of Gum Katira at 80-90ºC confirms it as a novel excipient for sustained drug delivery system.
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Moisture content determination
Moisture content of gummy excipients used in formulations can influence the chemical and physical stability of active pharmaceutical ingredients and also the formulation. The moisture content of natural polysaccharide used as drug release excipients should be ≤ 15% in according to the pharmacopoeia and WHO guidelines.
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Moisture content of Gum Katira powder was found to be 13.21 ± 0.% which is within the mentioned limits. So, in terms of moisture content Gum Katira can be successfully used in a sustained release formulation.
Microbial Load Study
The sample was analyzed for total aerobic microbial count and fungal count by pour plate method. Total aerobic count should be less than 1000 CFU/g and total fungal count should be less than 100 CFU/g to pass the microbial limit test. 31 Microbial count study shows that total number of colonies for aerobic count is 210 CFU/g and total fungal count 93 CFU/g which is within the mentioned limits. Therefore the Gum Katira can be used for formulation development.
Toxicity Study of Gum Katira
Acute toxicity study was conducted on mice with the gum katira which revealed no behavioral changes and also no mortality was observed even at a dose level of 2.0 g/kg body weight, after 24 hours of per-oral administration. Subacute toxicity study was conducted on rat whose haematological analysis (Table 1) after thirty days of oral administration showed no significant variance in the level of hemoglobin, RBC, WBC, neutrophil, eusinophil, monocyte, lymphocyte, SGOT, SGPT and platelets in treated animals as compared to that of the control group animals. Also, the histopathological studies (Figure 1 ) of treated animals revealed no significant tissue damage of the kidney and liver and were comparable to that of the control group. So, no abnormalities in histopathological studies were found. On the basis of the toxicity study conducted it can be concluded that the gum katira is safe to be used in the formulation.
Percentage swelling of Gum
Hydrophilic polymers undergo swelling at a rate proportional to the amount of polymer irrespective of the nature of the drug. Due to stress induced by ingresses water the polysaccharide matrix initially shows rapid swelling, with progressive increment in size along with entanglement of polymeric chain which forms a periphery gelatinous layer around the core through which diffusion of drug molecules takes place. 32 Thickness of gelatinous layer determines the drug release from matrix. Drug diffusion also depends on the viscosity of the swollen region which in turn depends on the amount of polymer in the matrix. During the swelling characteristic study it was observed that initially both the formulations showed rapid swelling and at around 8-9 th Values are expressed as mean ± SEM of 6 rats in each group. P<0.05 was considered significant. No significant difference was observed in any parameter.
hrs they attained maximum swelling after which there was a percentage decrease in swelling due to erosion of the axial layer, which promotes water penetration in the preceding layers. 33 The swelling performance of 1% w/v (gummy) of ELGKM and ELSAM are shown in the ( Figure 2) . The maximum percentage of swelling of Gum Katira was achieved at 11 th hrs but Sodium alginate at 7 th hr after which they start losing their integrity. ELGKM showed slow and continuous swelling up to 11 hrs followed by decrease in swelling percentage which may be due to polymeric relaxation, whereas ELSAM showed faster swelling followed by immedi- ately decrease in swelling as compared to ELGKM. It is also observed that percentage of swelling increases with increase in gum concentration up to a certain limit after which further increase in gum concentration decreases swelling due to inhibition of water penetration into the matrix. In the (Table 2) , the slope of percentage swelling vs. time indicates that rate of swelling of ELGKM in the dissolution media (pH-1.2 acidic media and pH-6.8 phosphate buffer) is greater than ELSAM. So, it is expected that the drug release from ELGKM should be more prolonged than that of ELSAM.
Rheological Study
In pseudoplastic flow the consistency curve begins at the origin. As the shear stress increases progressively, shear rate also increases, but the curve is not linear. These types of curves are generally exhibited by Non-Newtonian system such as polymeric solution of sodium alginate. 34 The rheogram of Gum Katira(1% w/v, 2% w/v) and sodium alginate (1%w/v) solution at different time interval (12 th and 24 th hrs) are graphically presented in (Figure 3) . The rheograms of aqueous dispersion of both gums indicate pseudoplastic flow. But it % w/v = Amt. of ingredients (mg) present in 100 ml solvent was also seen that at lower concentration of Gum Katira the curve does not follow proper pseudoplastic flow which is due to very weak molecular interaction among the polymer molecules. In the study, the viscosity of gum solution decreases with increase in rate of shear and so no single value can be used to express its viscosity. The entire system is most satisfactory representation of Gum Katira as a pseudoplastic material.
Characterization/ Evaluation of Microsphere Percentage of Yield and Encapsulation Efficiency
The percentage yield and encapsulation efficiency of Etodolac were optimum in all formulations. Yet, due to variation of polymer type, stirring speed and polymer drug ratio some formulation were affected. Like with the increase in rate and duration of stirring the drug loading was seen decreasing. Also, with increase in amount of coating polymer, Eudragit the drug loading increases to some extent. But, the drug loading increases upto an optimum ratio (gum katira: Etodolac 1:2) of Gum Katira and Etodolac after which any increase in the ratio decreases the drug loading (Table 3) .
Scanning Electron Microscope
The SEM is used to determine the particle size distribution, surface morphology, texture and also to examine the morphology of fracture or sectioned surface of the prepared microsphere. The absence of pore in the formulation is of major importance for the underlying drug release mechanisms because drug release through water filled cavities is much faster than though dense polymeric matrix network. SEM of ELGKM (F A , F B , F C & F D ), ELSAM (F E ) and Blank microsphere (F F ) are shown in the ( Figure 4 ). All microspheres were spherical in shape; smooth surfaced and had minute pores on the surface. The surface of ELGKM was found to be smooth bearing small pores whereas in case of ELSAM and Blank microsphere the surface was rough bearing larger pores. In the study, the formulations with Gum Katira bearing smooth surface showed slower rate and prolonged drug release as compared to the formulation without Gum Katira.
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Differential Scanning Calorimetry
DSC was performed to study the changing thermal behavior of the drug, polymer and gum during formulation. A sharp symmetric endothermic peak represents the melting point of the pure sample whereas a broad asymmetric curve in the DSC thermogram conveys about the presence of impurities in the sample. Generally, large endothermic and exothermic peak indicates the thermal decomposition of the sample. Also, the broad and large endothermic peak usually indicates the loss of water present in the compound. 36 Amorphous compound gives a broad peak due to the gradual decomposition of exudates structure but a crystalline solid require a fixed amount of energy for decomposition and gives a sharp peak. In (Figure 5 ), a sharp endothermic peak at 15 0 C and broad endothermic peak at 50-90 0 C suggests the melting point of Etodolac and melting range of Gum Katira respectively. The thermogram of the microsphere showed little endothermic peak shift from151.90 0 C to152.12 0 C which is negligible. From the DSC conducted, it is clear that Gum Katira does not produce any thermal changes with the drugs and other ingredients used in microsphere formulations. So, both gum and Etodolac are compatible with each other as they are essentials for sustained drug delivery system.
FTIR Study
FTIR was conducted to study chemical interaction between the active ingredient, Etodolac and all the other excipients used in the formulation. The entire observed spectrum is given in (Figure 6 ) where the characteristic peaks of ELGKM was compared with that of the standard spectrum of Etodolac and no chemical interaction was identifiable in IR profile of ELGKM. Etodolac having ether form shows the C-O stretching vibration at 1033.85 cm -1 . The other characteristic bands are shown at 1728.22 cm -1 for C=O stretching vibration of the COOH group, at 2970.38 cm -1 for N-H stretching vibration of secondary amine group and at 748.38 cm -1 for C-H stretching vibration of aromatic group. 37 So, FTIR study suggests that there is no appearance of new peak and disappearance of existing peak which denotes an absence of interaction between the drug and excipients used in microsphere formulations.
XRD study
According to the powder crystalline theory the crystalline substance have a well defined structure. Atoms, ions and molecules are arranged in a three dimensional lattice which results in tight packing of components so well defined edges and faces diffract X-ray in a regular pattern. Amorphous solids have curved and irregular surface so does not give well resolved dif- fractrogram. 38 The powdered X ray diffraction of Gum Katira, Etodolac and formulation are shown in the (Figure 7) where, the diffraction pattern of pure Etodolac and Etodolac loaded Gum Katira microsphere shows crystalline peak but Gum Katira alone gives amorphous peak. The result demonstrates that the crystalline peak of drug and formulation are almost similar but peak intensity diminishes in the formulation diffractrogram due to dilution of the drug with gum and polymer. So, the conducted XRD experiment also suggests that Etodolac is compatible with Gum Katira. Therefore the Gum Katira can be used as a novel matrix forming excipient for the sustained drug delivery system.
Dissolution Profile and Release rate kinetics
The mechanism of drug release from the microspheric formulation is biphasic in nature. Dissolution was carried out and it was observed that the drug release from the microspheres in acidic media pH-1.2 was too low in comparison to USP phosphate buffer media pH-6.8. Where, in buffer media at pH-6.8 the drug release gradually increased and followed a steady state (Figure 8 ). Such release profile of the drug is observed mainly due to variation in solubility of drug and percentage swelling of gum at different pH. The drug is less soluble at pH-1.2 and highly soluble at pH-6.8 which accounts for higher rate of drug release in phosphate buffer at pH-6.8 than in acidic media at pH-1.2. Also initial slow drug release reflects the time consuming processes of diffusion through the polymer wall, as well as the formation of pores and channels within the microspheres. Therefore, at pH-6.8 where the percentage of swelling of gum is high as observed in (Figure 2 ) there is an increase in pore size which accounts for better and increased drug release. he collected drug release data from the dissolution test were evaluated using number of kinetic models like Zero order 39 release kinetics Eq. 1., First Order 40 Eq. 2, Higuchi's square root of time equation 41 Eq. 3, Korsemeyer and Peppas equation 42 Eq. 4, and Hixon-Crowells cube root of time equation 43 Eq. 5. C=K 0 t (1) Where, K 0 is zero order rate constant expressed as concentration/ time and t is the time. LogC=LogC 0 -K 1 t/2.303 (2) Where, C 0 is the initial concentration of drug and K 1 is first order constant. Q=K h t (3) Where, K h is the constant reflecting the design variables of the system. M t /M ∞ = K kp t n (4) Where, Mt/M ∞ is the fraction of drug release, K kp is the release rate constant, n is the diffusional release exponent indicative of the drug release mechanism and t is the dissolution time. Q 0 1/3 -Q t 1/3 = K hc t (5) Where, Q t is the amount of the drug released in time t, Q 0 is the initial amount of drug in the formulation and K hc is the rate constant for Hixson-Crowell rate equation. The best fitted model was analyzed by comparing the correlation coefficient value of different mathematical models in (Table 4) . From the recorded data the correlation coefficient value of ELGKM (r 2 =0.9939) is found to be higher than that of ELSAM (r 2 =0.9486) in equal percentage of gum. Thus, Korsmeyers Peppas model was the best satisfactory mathematical model for ELGKM (1% w/v Gum Katira). Based on Korsmeyers Peppas model, the magnitude of release exponent "n" correspond to the release mechanism supercase II transport or anamolous transport, which can be concluded on comparing the value of n=3.012 which is greater than the value 0.89 (Table 5) . Similarly, for ELSAM the "n" value i.e. n=0.684 is within the range of 0.45 to 0.89 thus it follows non-fickian transport release mechanism. In this regard, the drug release from microspheric formulation of Gum Katira followed the supercase II transport mechanism whereas formulation with sodium alginate and Blank microsphere followed non fickian transport mechanisms.
CONCLUSION
The evaluation of the different physiochemical parameters of Gum Katira reveals its potential to be a superior matrix for sustained release. The stability in terms of rheology and safety profile showed the acceptability of formulations composing of Gum Katira. The microsphere prepared by double emulsion solvent evaporation method delivers the drug in a regular fashion for an extended period of time. Consequently, it can be concluded that the gum exudates of Cochlospermum religiosum, when incorporated with etodolac may be potential pharmaceutical formulation for the safe management of pain therapy.
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SUMMARY
• Gum Katira is a natural gum obtained from the plant Cochlospermum religiosum (Family Cochlospermaceae).
• On the basis of its physiochemical characters, Gum Katira is a good drug release retarding agent. and thus it acts as an excipint in the novel drug delivery system.
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